Evelo Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing oral biologics that act on cells in the small intestine with striking therapeutic effects throughout the …